RDInvesting Provides Investors with Free In-Depth Equity Reports on AMBA, HEB, TIBX and VEM

Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at www.RDInvesting.com and get exclusive access to our numerous stock reports and market updates.

Ambarella Inc. (NASDAQ:AMBA - News) shares increased 1.10 percent to close at $32.25 a share Tuesday. The stock traded between $31.44 and $32.84 on volume of 1.23 million shares traded. Analysts at Dougherty have recently initiated coverage on the company with a "neutral" rating. Shares of Ambarella have gained approximately 175.0 percent in the past year.

Find out more about Ambarella including full access to the free equity report at:
www.RDInvesting.com/AMBA

Hemispherx BioPharma, Inc. (NYSEMKT:HEB - News) shares increased 9.38 percent to close at $0.451 a share Tuesday. The stock traded between $0.44 and $0.51 on volume of 13.39 million shares traded. Analysts at Chardan have recently initiated coverage on the company with a “buy” rating. Shares of Hemispherx BioPharma have gained approximately 80.0 percent in the past year.

Find out more about Hemispherx BioPharma including full access to the free equity report at:
www.RDInvesting.com/HEB

Tibco Software Inc. (NASDAQ:TIBX - News) shares declined 3.16 percent to close at $22.71 a share Tuesday. The stock traded between $22.58 and $23.04 on volume of 4.05 million shares traded. Analysts at Wedbush have recently downgraded the company’s rating to "neutral" from "outperform". Shares of Tibco Software have gained approximately 3.0 percent in the past year.

Find out more about Tibco Software including full access to the free equity report at:
www.RDInvesting.com/TIBX

Violin Memory Inc. (NYSE:VMEM - News) shares declined 7.71 percent to close at $3.47 a share Tuesday. The stock traded between $3.38 and $3.70 on volume of 702,792 shares traded. Analysts at Barclays have recently downgraded the company’s rating to "underweight" from "equal weight". Shares of Violin Memory have fallen approximately 50.0 percent in the past year.

Find out more about Violin Memory including full access to the free equity report at:
www.RDInvesting.com/VMEM

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.

Contact:
Research Driven Investing
info@rdinvesting.com